Jean-Michel Sallenave Ph.D.

INSERM U1152, Hôpital Bichat, Paris, France

I obtained my PhD (Immunology of gestation) in Bordeaux, France. After a post-doctoral period in Edinburgh (Scotland, UK), where I worked on the role of the protease/antiprotease balance in lung mucosal inflammation, I moved to Pr J. Gauldie's lab (McMaster University, Hamilton, Canada) where I used gene transfer techniques to promote lung protection in inflammatory murine models (1992-1996). I then joined the MRC Center for Inflammation (Edinburgh, Scotland) as a PI (1996-2006) where my team worked on the role of antimicrobial molecules in Pseudomonas aeruginosa lung infection models. In 2006, I joined the Pasteur Institute (Paris, France, 2006-2014), as a PI and Professor of Immunology, working on TLR5-Pseudomonas and Influenza-proteases signalling pathways and the deleterious role of neutrophil host proteases in cystic fibrosis. In 2014, I moved to the INSERM U 1152 (Hôpital Bichat, Paris, France), where our team is working on deciphering the protective role of host endogenous antimicrobials and nanoparticles in lung inflammation in cystic fibrosis and other lung pathologies I have recently served on the advisory board for the : 10th World congress on Inflammation (Paris, 25-29/06/2011) and have participated in the organization of the « Lung Science Conferences » (European Respiratory Society) from 2013 to 2016 as co-‘Program coordinator’. I am currently a member of the organizing committe of the Lung Science Conference program (Estoril, Portugal), and a ‘Program advisor’ , responsible for over-seeing the scientific program at the annual ERS (European Research Society) congress.